These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Optic nerve sheath diameter, intracranial pressure and acute mountain sickness on Mount Everest: a longitudinal cohort study. Sutherland AI; Morris DS; Owen CG; Bron AJ; Roach RC Br J Sports Med; 2008 Mar; 42(3):183-8. PubMed ID: 18182624 [TBL] [Abstract][Full Text] [Related]
7. Ultrasonography of the Optic Nerve Sheath Diameter for Diagnosis and Monitoring of Acute Mountain Sickness: A Systematic Review. Lochner P; Falla M; Brigo F; Pohl M; Strapazzon G High Alt Med Biol; 2015 Sep; 16(3):195-203. PubMed ID: 26334584 [TBL] [Abstract][Full Text] [Related]
8. Increased Cytokines at High Altitude: Lack of Effect of Ibuprofen on Acute Mountain Sickness, Physiological Variables, or Cytokine Levels. Lundeberg J; Feiner JR; Schober A; Sall JW; Eilers H; Bickler PE High Alt Med Biol; 2018 Sep; 19(3):249-258. PubMed ID: 29924642 [TBL] [Abstract][Full Text] [Related]
9. The effects of a 5-lipoxygenase inhibitor on acute mountain sickness and urinary leukotriene e4 after ascent to high altitude. Grissom CK; Richer LD; Elstad MR Chest; 2005 Feb; 127(2):565-70. PubMed ID: 15705997 [TBL] [Abstract][Full Text] [Related]
10. Remote ischemic preconditioning does not prevent acute mountain sickness after rapid ascent to 3,450 m. Berger MM; Macholz F; Lehmann L; Dankl D; Hochreiter M; Bacher B; Bärtsch P; Mairbäurl H J Appl Physiol (1985); 2017 Nov; 123(5):1228-1234. PubMed ID: 28798201 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and time course of acute mountain sickness in older children and adolescents after rapid ascent to 3450 meters. Bloch J; Duplain H; Rimoldi SF; Stuber T; Kriemler S; Allemann Y; Sartori C; Scherrer U Pediatrics; 2009 Jan; 123(1):1-5. PubMed ID: 19117853 [TBL] [Abstract][Full Text] [Related]
13. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). Gertsch JH; Basnyat B; Johnson EW; Onopa J; Holck PS BMJ; 2004 Apr; 328(7443):797. PubMed ID: 15070635 [TBL] [Abstract][Full Text] [Related]
14. Rate of ascent and acute mountain sickness at high altitude. Hsu TY; Weng YM; Chiu YH; Li WC; Chen PY; Wang SH; Huang KF; Kao WF; Chiu TF; Chen JC Clin J Sport Med; 2015 Mar; 25(2):95-104. PubMed ID: 24751723 [TBL] [Abstract][Full Text] [Related]
15. Altitude Sickness Prevention with Ibuprofen Relative to Acetazolamide. Burns P; Lipman GS; Warner K; Jurkiewicz C; Phillips C; Sanders L; Soto M; Hackett P Am J Med; 2019 Feb; 132(2):247-251. PubMed ID: 30419226 [TBL] [Abstract][Full Text] [Related]
16. Acute mountain sickness in children at 4380 meters in the Himalayas. Pradhan S; Yadav S; Neupane P; Subedi P Wilderness Environ Med; 2009; 20(4):359-63. PubMed ID: 20030445 [TBL] [Abstract][Full Text] [Related]
17. Interstitial Pulmonary Edema Assessed by Lung Ultrasound on Ascent to High Altitude and Slight Association with Acute Mountain Sickness: A Prospective Observational Study. Alsup C; Lipman GS; Pomeranz D; Huang RW; Burns P; Juul N; Phillips C; Jurkiewicz C; Cheffers M; Evans K; Saraswathula A; Baumeister P; Lai L; Rainey J; Lobo V High Alt Med Biol; 2019 Jun; 20(2):150-156. PubMed ID: 31045443 [No Abstract] [Full Text] [Related]
18. Acute mountain sickness and ascent rates in trekkers above 2500 m in the Nepali Himalaya. Vardy J; Vardy J; Judge K Aviat Space Environ Med; 2006 Jul; 77(7):742-4. PubMed ID: 16856361 [TBL] [Abstract][Full Text] [Related]
19. Day of Ascent Dosing of Acetazolamide for Prevention of Acute Mountain Sickness. Lipman GS; Jurkiewicz C; Winstead-Derlega C; Navlyt A; Burns P; Walker A; Phillips C; Reilly A; Burnier A; Romero J; Warner K; Hackett P High Alt Med Biol; 2019 Sep; 20(3):271-278. PubMed ID: 31259608 [No Abstract] [Full Text] [Related]